Klaus Christensen
Corporate Officer/Principal at WNTRESEARCH AB
Network origin in Klaus Christensen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Other | 18 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Klaus Christensen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PROBI AB | Biotechnology | Director/Board Member Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member | |
| University of Oxford | College/University | Corporate Officer/Principal | |
| The University of Manchester | College/University | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Uppsala | College/University | Graduate Degree Graduate Degree | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Chief Operating Officer | |
| University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
| University of Gothenburg | College/University | Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
| Handelshögskolan i Göteborg | College/University | Undergraduate Degree | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| The European Medicines Agency | National Agency | Corporate Officer/Principal | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| LIDDS AB | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| OxyPharma AB | Chief Executive Officer | ||
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
| XINTELA AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member | |
| IDOGEN AB (PUBL) | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Fermion Ltd. | Director/Board Member | ||
| Wntresearch Incentive AB | Director/Board Member Director/Board Member Director/Board Member | ||
| REDWOOD PHARMA AB | Pharmaceuticals: Major | Chairman | |
| EVAXION BIOTECH A/S | Biotechnology | Chief Executive Officer | |
| LIPUM AB | Biotechnology | Chairman | |
| Ub-Consulting AB | Chief Executive Officer | ||
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| A Bioscience Incentive AB | Chairman | ||
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| ANNEXIN PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
Innovativa Mindre Life Science
 Innovativa Mindre Life Science Miscellaneous Commercial ServicesCommercial Services Innovativa Mindre Life Science is an association of small and medium-sized Swedish companies that conduct research in the field of pharmaceuticals and medical technology. | Miscellaneous Commercial Services | Director/Board Member | |
| Asklepios Medicin Handelsbolag | Corporate Officer/Principal | ||
Sand Medical AB
 Sand Medical AB Medical/Nursing ServicesHealth Services Sand Medical AB provides medical care services. The private company is based in Stockholm, Sweden. | Medical/Nursing Services | Chairman | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | General Counsel | |
| Anstren Consulting AB | Director/Board Member | ||
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Chief Executive Officer | |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
 Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Apotekarsocieteten | Corporate Officer/Principal | ||
| Infans Capital AB | Director/Board Member | ||
| Nordic Alliance Tankers AB | Director/Board Member | ||
| Snevringe AB | Chairman | ||
| ALZINOVA AB | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| Sweden | 40 |
| United States | 5 |
| United Kingdom | 4 |
| Denmark | 3 |
| Israel | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 9 |
| Government | 2 |
| Commercial Services | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 53 |
| Corporate Officer/Principal | 34 |
| Chief Executive Officer | 17 |
| Chairman | 17 |
| Chief Tech/Sci/R&D Officer | 11 |
Most connected contacts
| Insiders | |
|---|---|
| Dennis Bang Henriksen | 19 |
| Peter Jan Sture Ström | 15 |
| Ulf Björklund | 14 |
| Jan Nilsson | 12 |
| Per-Ola Forsberg | 11 |
| Christer Nordstedt | 10 |
| Anders Rabbe | 9 |
| Per Norlén | 9 |
| Pernilla Sandwall | 8 |
| Tommy Evert Andersson | 6 |
| Peter Morsing | 6 |
| Jonas Bergh | 6 |
| Gudrun Anstrén | 5 |
| Anders Tidfors | 5 |
| Janna Sand-Dejmek | 4 |
- Stock Market
- Insiders
- Klaus Christensen
- Company connections
